📣 Send us your press release
Site updates every 15 minutes
Health

Klaria Q2 2026: Sales Flat, R&D Costs Down, Loss Narrowed

Klaria released its interim report for the second quarter of 2026. The company reported zero net sales but saw a significant reduction in research and development expenses, leading to a smaller net loss.

31 August 2026
Klaria Q2 2026: Sales Flat, R&D Costs Down, Loss Narrowed
Image is an AI-generated illustration

Klaria AB has reported its financial results for the second quarter of 2026, covering the period from April 1 to June 30. The company recorded no net sales, with the figure remaining at 0.0 MSEK, consistent with the same period in the prior year.

Research and development expenses for the quarter decreased to 4.4 MSEK, down from 7.1 MSEK in the corresponding period of 2025. This reduction in R&D spending contributed to a narrowed net loss after tax, which amounted to -12.9 MSEK, an improvement from -20.1 MSEK in the second quarter of 2025. Earnings per share were -0.05 SEK compared to -0.17 SEK previously.

Cash flow from operating activities was negative at -14.8 MSEK, a decline from -2.3 MSEK in the previous year's second quarter. However, the company's liquid assets increased to 8.5 MSEK at the end of the reporting period, up from 2.0 MSEK. Group equity stood at -33.6 MSEK as of June 30, 2026.

Original source: news.cision.com